Fintepla

Product manufactured by Zogenix, Inc.

Application Nr Approved Date Route Status External Links
NDA212102 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Fintepla Is Indicated For The Treatment Of Seizures Associated With Dravet Syndrome In Patients 2 Years Of Age And Older. Fintepla Is Indicated For The Treatment Of Seizures Associated With Dravet Syndrome In Patients 2 Years Of Age And Older. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Fenfluramine FENFLURAMINE ZINC294

Comments